ctSearch Results
Original Query
What is cancer prolymphocytic leukemia?
Search Results
- cancer prolymphocytic leukemia
Leukemia, cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream. Prolymphocytic leukemia is a type of chronic lymphocytic leukemia (CLL), in which too many immature white blood cells (prolymphocytes) are found in the blood and bone marrow. Prolymphocytic leukemia usually progresses more rapidly than classic CLL. Also called PLL. Cancer is a term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.
Preview- One can assume that, PURPOSE This phase I trial is studying the side effects and the best dose of carfilzomib in treating patients with relapsed or refractory chronic lymphocytic leukemia(CLL),small lymphocytic lymphoma(SLL), or prolymphocytic leukemia (PLL. Refractory is in medicine, describes a disease or condition that does not respond to treatment. Chronic is a disease or condition that persists or progresses over a long period of time. CLL is an indolent (slow-growing) cancer in which too many immature lymphocytes (white blood cells) are found mostly in the blood and bone marrow. Sometimes, in later stages of the disease, cancer cells are found in the lymph nodes and the disease is called small lymphocytic lymphoma. Also called chronic lymphocytic leukemia. Small lymphocytic lymphoma is an indolent (slow-growing) type of lymphoma in which too many immature lymphocytes (white blood cells) are found mostly in the lymph nodes. This causes the lymph nodes to become larger than normal. Sometimes cancer cells are found in the blood and bone marrow, and the disease is called chronic lymphocytic leukemia. The disease is most often seen in people older than 50 years. Small lymphocytic lymphoma is a type of non-Hodgkin Lymphoma. Also called SLL and well-differentiated lymphocytic lymphoma. Carfilzomib is a drug used to treat multiple myeloma that has not gotten better with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Carfilzomib blocks the action of enzymes called proteasomes, and may kill cancer cells. It is a type of proteasome inhibitor. Also called Kyprolis. Chronic lymphocytic leukemia is an indolent (slow-growing) cancer in which too many immature lymphocytes (white blood cells) are found mostly in the blood and bone marrow. Sometimes, in later stages of the disease, cancer cells are found in the lymph nodes and the disease is called small lymphocytic lymphoma. Also called CLL. PLL is a type of chronic lymphocytic leukemia (CLL) in which too many immature white blood cells (prolymphocytes) are found in the blood and bone marrow. PLL usually progresses more rapidly than classic CLL. Also called prolymphocytic leukemia. SLL is an indolent (slow-growing) type of lymphoma in which too many immature lymphocytes (white blood cells) are found mostly in the lymph nodes. This causes the lymph nodes to become larger than normal. Sometimes cancer cells are found in the blood and bone marrow, and the disease is called chronic lymphocytic leukemia. The disease is most often seen in people older than 50 years. SLL is a type of non-Hodgkin Lymphoma. Also called small lymphocytic lymphoma and well-differentiated lymphocytic lymphoma. Phase I trial is the first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments. Lymphoma, cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
- Seemingly, t-cell prolymphocytic leukemia normally requires immediate treatment. T-PLL does not respond to most chemotherapy treatments and is difficult to treat. Cell is the individual unit that makes up the tissues of the body. All living things are made up of one or more cells. Chemotherapy, treatment with drugs that kill cancer cells.
- One can presume that, age T-cell prolymphocytic leukemia affects people over 30 years of age.
NEW: Try our Cancer Expert Fact Search, and get direct access to our Knowledge Base (KB).
Disclaimer: On occasion, search results will contain fragmented, and erroneous (misspelled, incorrect grammar and malformatted) text. It is not possible, for our Bots to automatically correct these, afterall they represent the corpus created by individuals and/or other Bots and who have placed it on the Internet. Keep in mind, Cancer Expert Search is a search engine, and we are required to return search results as closely resembling their original format, when they were discovered by our Bots (including all errors).